Editors' Picks
Lpath: The Leader In Lipidomics by Bay Area Biotech
Vistaprint: Introducing Investors To A Company That Will Be Lowering Guidance Soon by Money Investor
Why Did Pain Therapeutics Increase Over 25%? by C.R. Jackson
Rowan: Push Into Ultra-Deepwater Could Bring Profits To Investors by Power Hedge
BlackRock: This Industry-Leading Asset Manager Is Like A Rock by Saibus Research
Carhops, Coneys, And Healthcare: Why I'm Short Sonic Drive-Ins, Part I by H.J. Huneycutt
China Cord Blood: Evaluating Buyout Potential by Richard Pearson
Long Ideas
Mandalay Digital: An Alternative Revenue Source For The Wireless Carriers by Matt Gohd
Is Barrick Gold A Good Investment? by IAEResearch
Natural Gas Boom's Top 3 LNG Exporters: 2nd Promising Player, Dominion Resources by Stephan Dube
Lpath: The Leader In Lipidomics by Bay Area Biotech
Intel: Something Big Is Coming On May 6 by Ashraf Eassa
Buy, Sell Or Hold The Brand New 'CST Brands' Stock? by Scott Eymer
Newmont Mining Is Ready To Rumble by Cory Renauer
Sirius XM Reaches $3.39; Time To Take Profits? by Stephen Faulkner
Is Google Worth That Much More Than Microsoft? by Benedict Tubuo (Beevest)
How Apple's Pain Is Intel's Gain by Sneha Shah
Sirius XM To Increase Share Buyback Program? by Spencer Osborne
6 Reasons To Buy Licensing Giant Iconix Brand Group by Chris Katje
Sirius XM Tests New 52 Week Highs by Spencer Osborne
Why Did Pain Therapeutics Increase Over 25%? by C.R. Jackson
Buffalo Wild Wings Not Chicken When It Comes To Betting On Beer by Chris Katje
Will The Galaxy S4 Win It For Samsung In India? by StockRiters
A Sweeter Deal On The Horizon For Prolor Biotech? by Stefan Bordonaro
Jamba Squeezing Up A Turnaround by Wall Street Strategies
Rowan: Push Into Ultra-Deepwater Could Bring Profits To Investors by Power Hedge
Galectin Therapeutics Gets A Bid After Promising Results by Brian L. Wilson
BlackRock: This Industry-Leading Asset Manager Is Like A Rock by Saibus Research
The Housing Fab 4 by Lamarcus R. Coleman
ICAD's Double-Digit Growth Looks Sustainable by Brian Marckx
The Gulf Of Mexico Is A Winner For This Independent by Todd Campbell
Microsoft Vs Sony: Game On! by Fund Gurus
Canadian Natural Resources Is Ready To Reverse The Recent Trend by IAEResearch
Wipro's Spin-Off Enough To Close Industry P/E Gap by Bram de Haas
Swinging For The Fences With Advanced Cell Technology by Michael J. Ray
Will Hewlett-Packard Make A Turnaround? by IAEResearch
Netflix Loses Movies From Time Warner, MGM; Viacom Could Be Next by Renee Ann Butler
Celsion's A Fighter by Quoth the Raven
ViroPharma's Maribavir: Rising Like Phoenix by Theodore Cohen
Behind The Rise In First Solar by Dana Blankenhorn
Weak Quarter At Auxilium Overshadows Execution On Long-Term Strategy by PropThink
Bull Of The Day: Lumber Liquidators by Zacks Investment Research
What Tim Cook Must Do To Turn Apple Around by Mark Hibben
Shame On You, Apple by George Acs
Lee Enterprises's Revenue Is Starting To Stabilize by Saibus Research
Russian Nukes Will No Longer Pack Power: A Case For Uranium Energy Corp. by Biz Bluetree
Sina's Stock Jumps As Alibaba Picks Up A Stake In Weibo by Trefis
Eaton Corporation PLC: Outstanding Investment, But Wait For A Pullback by Ray Merola
Atossa Genetics: Pullback In Shares Of Breast Cancer Testing Firm Present Opportunity by Stock Reversals
Playing The Mobile Ad Market With Google, Facebook And Expedia by Renee Ann Butler
The 'Retire Young' Portfolio: This Entertainment Giant Will Add Value by Jacob Steinberg
China Cord Blood: Evaluating Buyout Potential by Richard Pearson
Too Many Bears In The BlackBerry Bushes by Black Spruce
A Bullish Case For BlackBerry, The Death Of Tablets And A Strong Q10 Launch by Renee Ann Butler
Vivus And Anti-Obesity Sector Benefit From New Insurance Deal by Spencer Osborne
BioLineRx Pipeline Returns To The Winner's Circle by Len Zehr
Gross Margins For Green Mountain Coffee Roasters And SodaStream by Seth Golden
Intel: Slow But Steady Wins The Race by Renee Ann Butler
IBM: Revenues Flat But Stock Should Still Climb by Mayukh Mukherjee
Ford Rallies Ahead Of April Sales Report; GM Reaches Fresh 52-Week High by Selerity Research
Suncor Is Growing On All Fronts - Dividend, Share Repurchases, And Production by Devon Shire
Short Ideas
Blackberry Continues To Lack Inspiration by Richard Cox
Vistaprint: Introducing Investors To A Company That Will Be Lowering Guidance Soon by Money Investor
OXiGENE's Oncology Drugs Have Run Their Course by Bay Area Biotech
Carhops, Coneys, And Healthcare: Why I'm Short Sonic Drive-Ins, Part I by H.J. Huneycutt
Facebook's Current Price Is Unsustainable by Alistair Robson
Quick Picks & Lists
Caution May Be Warranted With These Stocks by David Pinsen
3 Undervalued U.S. Equities With Strong Earnings Growth by Black Coral Research
Las Vegas Sands Continues To Rolls Sevens by Bret Jensen
Facebook To Play Search Against Google by Cecil Sales
Undervalued Growth Stocks Under $10 by Codespeed
We Believe That USG Is The Place To Be by Ulfberht Capital
Short Sellers Are Going After These 5 Names by Bill Maurer
Short Sellers Are Running Away From These 5 Names by Bill Maurer
Bear Of The Day: Select Comfort by Zacks Investment Research
April Car Sales: Strength In Numbers by TheCarConnection
Tesla's Short Squeeze Is Here by Adam Betancourt
We Like Cigna by Ulfberht Capital
Valero Will Bounce Back by Bret Jensen
Looking Into The Specialty Pharmacy Sector by Dutch Trader
Deutsche Bank: The Bond Industry's Reform Will Lead To Further Consolidation by Trefis
Cisco Systems: A Strong Redoubt For An Uncertain Market by Bret Jensen
Why BioMarin, Catalyst Pharmaceutical Partners And Vertex Are Expected To Outperform by Tom Welch
Deckers Investors Might Be Missing The Bigger Picture by Keep It Simple
5 Stocks Under $10 Attractively Valued With Catalysts For Upside by David Alton Clark
Fund Holdings
It's Easy To See Why A Hedge Fund Billionaire Is Buying MetLife Shares by Hawkinvest
Billionaire T. Boone Pickens' Long-Term Stock Picks by Insider Monkey
Hedge Funds Are Buying These 3 Biotech Small Caps Trading Below Lowest Target Price by Kapitall
Insider Ownership
Bank Stocks Insiders Are Still Buying by Bret Jensen
Healthcare Providers With High Insider Ownerships by Markus Aarnio
IPO Analysis
IPO Preview: ING U.S. by IPOdesktop
IPO Preview: Insys Therapeutics by IPOdesktop
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario